Table 4 Comparison of baseline norepinephrine level, oxidative stress, and mitochondrial function between clinical AF and subclinical AF patients.

From: Effects of sodium-glucose cotransporter-2 inhibitor on atrial high-rate episodes in patients with cardiovascular implantable electronic device: a randomized controlled trial

Laboratory parameters

Clinical AF (n = 36)

Subclinical AF (n = 18)

P value

Norepinephrine level (pg/mL)

303.5, 231.7–442.0

360.1, 214.8–529.0

0.556

Cellular oxidative stress (arbitrary unit)

24840.0, 20980.0–30989.0

25418.0, 21366.0–31390.0

0.810

Mitochondrial oxidative stress (arbitrary unit)

3447.0, 2622.8–4201.8

2531.5, 2204.2–4428.5

0.281

Mitochondrial mass (arbitrary unit)

26538.0, 19183.2–37901.2

21107.0, 15225.5–32483.5

0.168

Mitochondrial oxidative stress/ mass ratio

0.1, 0.1–0.2

0.1, 0.1–0.2

0.780

Basal respiration (pMol/min)

72.1, 47.4–94.4

97.2, 52.1–152.6

0.022*

Maximal respiration (pMol/min)

101.0, 46.0–175.1

112.5, 31.9–208.8

0.452

Proton leak (pMol/min)

22.6, 6.0–36.0

29.1, 12.2–58.8

0.407

ATP production (pMol/min)

57.3, 24.7–73.2

78.6, 45.7–112.0

0.015*

%Spare respiration capacity

157.4, 134.1–206.8

152.0, 119.8–204.5

0.622

%Coupling efficiency

79.3, 73.1–90.4

83.3, 79.3–93.1

0.198

  1. Data are shown as median, IQR unless specified.
  2. *p value < 0.05.